Vital signs: Variation among States in prescribing of opioid pain relievers and benzodiazepines — United States, 2012

Morbidity and Mortality Weekly Report

Volumn , Issue 26, 2014, Pages 563-568

  Paulozzi, Leonard J ^a   Mack, Karin A ^a   Hockenberry, Jason M ^b  

^a NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; NARCOTIC ANALGESIC AGENT;

ARTICLE; CLINICAL PRACTICE; FACTUAL DATABASE; HUMAN; INAPPROPRIATE PRESCRIBING; PAIN; PRESCRIPTION; STATISTICS; UNITED STATES;

ANALGESICS, OPIOID; BENZODIAZEPINES; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; HUMANS; INAPPROPRIATE PRESCRIBING; PAIN; PHYSICIAN'S PRACTICE PATTERNS; UNITED STATES;

EID: 84903692269     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. International Narcotics Control Board. Report of the International Narcotics Control Board on the availability of internationally controlled drugs: enduring adequate access for medical and scientific purposes. Vienna, Austria: International Narcotics Control Board; 2010. Available at http://www.incb.org/documents/Publications/AnnualReports/AR2010/Supplement-AR10_availability_English.pdf.
2. Ballantyne J. “Safe and effective when used as directed”: the case of chronic use of opioid analgesics. J Med Tox 2012;8:417-23.
3. Paulozzi L., Ryan GW. Opioid analgesics and rates of fatal drug poisoning in the United States. Am J Prev Med 2006;31:506-11.
4. Cicero T, Surratt H, Inciardi J, Munoz A. Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States. Pharmacoepidemiol Drug Safety 2007;16:827-40.
5. McDonald D, Carlson K, Izrael D. Geographic variation in opioid prescribing in the U.S. J Pain 2012;13:988-96.
6. Jones JD, Mogali S, Comer SD. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend 2012;125:8-18.
7. Zhang Y, Steinman M, Kaplan C. Geographic variations in outpatient antibiotic prescribing in older adults. Arch Intern Med 2012;172:1465-71.
8. Cox E, Motheral B, Henderson R, Mager D. Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: results from a commercially insured US sample. Pediatrics 2003; 111:237-43.
9. Munson J, Morden N, Goodman D, Valle L, Wennberg J. The Dartmouth atlas of Medicare prescription drug use 2013. Hanover, NH: Dartmouth Institute for Health Policy and Clinical Practice, Center for Health Policy Research; 2013. Available at http://www.dartmouthatlas.org/downloads/reports/prescription_drug_atlas_101513.pdf.
10. Weinstein J, Lurie J, Olson P, Bronner K, Fisher E. United States’ trends and regional variations in lumbar spine surgery: 1992-2003. Spine 2006;31:2707-14.
11. Fisher E, Wennberg D, Stukel T, Gottlieb D, Lucas F, Pinder E. The implications of regional variation in Medicare spending. Part 2: health outcomes and satisfaction with care. Ann Int Med 2003;138:288-98.
12. Yasaitis L, Fisher E, Skinner J, Chandra A. Hospital quality and intensity of spending: is there an association. Health Affairs 2009;28:w566-72.
13. Baumblatt J, Wiedeman C, Dunn J, Schaffner W, Paulozzi L, Jones T. High-risk use by patients prescribed opioids for pain and its role in overdose deaths. JAMA Int Med 2014;174:796-801.
14. Sauber-Schatz E, Mack K, Diekman S, Paulozzi L. Associations between pain clinic density and distributions of opioid pain relievers, drug-related deaths, hospitalizations, emergency department visits, and neonatal abstinence syndrome in Florida. Drug Alcohol Depend 2013;133:161-6.
15. Modarai F, Mack K, Hicks P, et al. Relationship of opioid prescription sales and overdoses, North Carolina. Drug Alcohol Depend 2013;132:81-6.
16. Prescription Drug Monitoring Program Center of Excellence at Brandeis University. Mandating PDMP participation by medical providers: current status and experience in selected states. Waltham, MA: Heller School for Social Policy and Management, Prescription Drug Monitoring Program Center of Excellence at Brandeis; 2014. Available at http://www.pdmpexcellence.org/sites/all/pdfs/COE%20briefing%20on%20mandates%20revised_a.pdf.
17. Surratt H, O’Grady C, Kurtz S, et al. Reductions in prescription opioid diversion following recent legislative interventions in Florida. Pharmacoepidemiol Drug Safety 2014;23:314-20.
18. CDC. Decline in drug overdose deaths after state policy changes— Florida, 2010-2012. MMWR 2014;63(Early Release).